Cumulus Neuroscience
Former CEO PathXL, pioneering digital pathology company acquired by Philips Healthcare in 2016. Board member of lifesciences / deep tech companies and QUB Ventures.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cumulus Neuroscience
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.